ABHI US Accelerator 2025 Launches With 21 UK HealthTech Companies Looking to Scale in The US
Summary
None Now in its eighth year, the ABHI US Accelerator has generated significant results, with over $150 million in business won by participating companies.The Association of British HealthTech Industries (ABHI) has announced the eighth cohort of its flagship US Accelerator programme, with 21 medical device, diagnostics, and digital health companies ready to access the US healthcare market.Officially launched at a two-day bootcamp in London ahead of their mission to New Jersey and Philadelphia, the companies will take part in the accelerator programme to help scale their business in the US.By leveraging ABHIs extensive network of hospital systems, life science communities, and mentors, companies can refine their US strategy, mitigate market entry risks, and expand their operations. They will also take part in four trade missions to key life sciences states in the US and gain access to facilities and faculty support at the Dell Medical School in Austin. Psyomics A platform designed to capture comprehensive patient information, supporting intake, triage, and assessment within adult mental and behavioral health services. VitVio Leveraging AI and computer vision to make operating rooms more efficient with less administrative burden .Members of the 2025 cohort attending their kick-off bootcamp in April 2025.This cohort joins a legacy of 150 US Accelerator alumni including Skin Analytics, Peppy, Radar Healthcare, Inicio Health, Lumeon and Ufonia.The ABHI US Accelerator has generated significant results, with over $150 million in business won by participating companies. By working with this new cohort, we look forward to fostering meaningful collaborations that enable these companies to thrive within Austins dynamic life sciences ecosystem and expand their impact across the country.